Publicacións en colaboración con investigadores/as de Hospital General Universitario de Valencia (19)

2024

  1. Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in infants, Spain, October 2023 to January 2024

    Eurosurveillance, Vol. 29, Núm. 6

2021

  1. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant

    Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414

2019

  1. Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain

    Open Forum Infectious Diseases, Vol. 6, Núm. 2

2017

  1. Drug resistance mutations in HIV-2 patients failing raltegravir and influence on dolutegravir response

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 7, pp. 2083-2088

  2. HIV type 2 epidemic in Spain: Challenges and missing opportunities

    AIDS, Vol. 31, Núm. 10, pp. 1353-1364

  3. Human T-lymphotropic virus type 1 infection and disease in Spain

    AIDS, Vol. 31, Núm. 12, pp. 1653-1663

2014

  1. HIV-2 and HTLV-1 infections in Spain, a non-endemic region

    AIDS Reviews, Vol. 16, Núm. 3, pp. 152-159

  2. HIV-2 viral tropism influences CD4+ T cell count regardless of viral load

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 8, pp. 2191-2194

2013

  1. Viral infections of the central nervous system in Spain: A prospective study

    Journal of Medical Virology, Vol. 85, Núm. 3, pp. 554-562

2012

  1. Trends in the prevalence and distribution of HTLV-1 and HTLV-2 infections in Spain

    Virology Journal, Vol. 9, Núm. 1

2011

  1. HTLV infection among foreign pregnant women living in Spain

    Journal of Clinical Virology, Vol. 52, Núm. 2, pp. 119-122

2010

  1. Prevalence of HTLV-1/2 infections in Spain: A cross-sectional hospital-based survey

    AIDS Research and Human Retroviruses, Vol. 26, Núm. 8, pp. 861-864

2009

  1. Seroprevalence of HTLV-1/2 infection among native and immigrant pregnant women in Spain

    AIDS Research and Human Retroviruses, Vol. 25, Núm. 6, pp. 551-554

2007

  1. Infection by the type 2 human immunodeficiency virus and types 1 and 2 human lymphotropic virus in Spain

    Medicina Clinica

2005

  1. Molecular epidemiology of HTLV-2 infection among intravenous drug users in Spain

    Journal of Clinical Virology, Vol. 33, Núm. 1, pp. 65-70

  2. Resistance to nonnucleoside reverse-transcriptase inhibitors and prevalence of HIV type 1 non-B subtypes are increasing among persons with recent infection in Spain

    Clinical Infectious Diseases, Vol. 41, Núm. 9, pp. 1350-1354

2004

  1. HIV-2 and HTLV-I/II infections in Spain

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 22, Núm. 3, pp. 177-182

2000

  1. Prevalence of HTLV infection in pregnant women in Spain

    Sexually Transmitted Infections, Vol. 76, Núm. 5, pp. 366-370

1996

  1. Epidemiology of HIV-2 infection in Spain

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 15, Núm. 5, pp. 383-388